Header Logo

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to Venugopal, Parameswaran
Item TypeName
Concept Burkitt Lymphoma
Concept Lymphoma, Large B-Cell, Diffuse
Concept Lymphoma, Non-Hodgkin
Concept Lymphoma, B-Cell
Concept Lymphoma, Mantle-Cell
Concept Lymphoma, Follicular
Concept Lymphoma
Concept Lymphoma, B-Cell, Marginal Zone
Academic Article The combination of fludarabine, cyclophosphamide, and granulocyte-macrophage colony-stimulating factor in the treatment of patients with relapsed chronic lymphocytic leukemia and low-grade Non-Hodgkin's lymphoma.
Academic Article Autologous stem cell transplantation following induction therapy with an anthracycline-based regimen including interferon-alpha for low-grade non-Hodgkin's lymphoma.
Academic Article Posttransplant lymphoproliferative disorder: extranodal marginal zone lymphoma occurring after renal transplantation.
Academic Article Efficacy and safety of rituximab combined with ESHAP chemotherapy for the treatment of relapsed/refractory aggressive B-cell non-Hodgkin lymphoma.
Academic Article Safety and efficacy of combination therapy with fludarabine, mitoxantrone, and rituximab followed by yttrium-90 ibritumomab tiuxetan and maintenance rituximab as front-line therapy for patients with follicular or marginal zone lymphoma.
Academic Article Granulocyte-macrophage colony stimulating factor-induced immune priming of cyclophosphamide, doxorubicin, vincristine, and prednisone with rituximab chemoimmunotherapy in previously untreated patients with diffuse large B-cell lymphoma and mantle cell lymphoma.
Academic Article Relapsed non-Hodgkin lymphoma in fraternal twins managed successfully with rituximab maintenance therapy.
Academic Article Durable remission of intravascular lymphoma with central nervous system involvement following chemotherapy and rituximab.
Academic Article GM-CSF plus rituximab immunotherapy: translation of biologic mechanisms into therapy for indolent B-cell lymphomas.
Academic Article Efficacy and safety of clofarabine in relapsed and/or refractory non-Hodgkin lymphoma, including rituximab-refractory patients.
Academic Article Long-term remission of paroxysmal nocturnal hemoglobinuria following chemoimmunotherapy for non-Hodgkin lymphoma.
Academic Article Impact of insulin-like growth factor 1 and insulin-like growth factor binding proteins on outcomes in acute myeloid leukemia.
Academic Article Bendamustine and Rituximab: Complete Response in a 62-Year-Old Female with an Aggressive Lymphoma and an Ejection Fraction of 20.
Academic Article Impact of treatment variability on survival in immuno-competent and immuno-compromised patients with primary central nervous lymphoma.
Academic Article Impact of cachexia on outcomes in aggressive lymphomas.
Academic Article Breast implant-associated anaplastic large-cell lymphoma and the role of brentuximab vedotin (SGN-35) therapy: A case report and review of the literature.
Academic Article Phase 2 study of CHOP-R-14 followed by 90Y-ibritumomab tiuxetan in patients with previously untreated diffuse large B-cell lymphoma.
Academic Article Randomized Phase II Study of R-CHOP With or Without Bortezomib in Previously Untreated Patients With Non-Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma.
Academic Article Metabolic changes associated with metformin potentiates Bcl-2 inhibitor, Venetoclax, and CDK9 inhibitor, BAY1143572 and reduces viability of lymphoma cells.
Academic Article Phase 1 study of lenalidomide plus dose-adjusted EPOCH-R in patients with aggressive B-cell lymphomas with deregulated MYC and BCL2.
Academic Article Evaluation of the impact of cachexia on clinical outcomes in aggressive lymphoma.
Academic Article When Monoclonal Gammopathy is of Renal Significance: A Case Study of Crystalglobulinemia From Chicago Multiple Myeloma Rounds.
Academic Article Orbital Mucosa-Associated Lymphoid Tissue Lymphoma and Primary Cutaneous Classical Hodgkin Lymphoma: A Rare Case Report and Review of the Literature.
Academic Article Significance of isolated deletion (20q) in donor cells after allogeneic hematopoietic cell transplantation.
Academic Article Burkitt lymphoma in the modern era: real-world outcomes and prognostication across 30 US cancer centers.
Academic Article Outcomes of Burkitt lymphoma with central nervous system involvement: evidence from a large multicenter cohort study.
Academic Article HIV-associated Burkitt lymphoma: outcomes from a US-UK collaborative analysis.
Academic Article EBV-positive PCNSL in older patients: incidence, characteristics, tumor pathology, and outcomes across a large multicenter cohort.
Academic Article Older patients with primary central nervous system lymphoma: Survival and prognostication across 20 U.S. cancer centers.
Academic Article Parsaclisib, a PI3Kd inhibitor, in relapsed and refractory mantle cell lymphoma (CITADEL-205): a phase 2 study.
Search Criteria
  • Lymphoma